The landscape of diabetes care is changing with the emergence of transdermal GLP-1 delivery . These novel patches offer a potentially less invasive alternative to injections for individuals living with diabetes mellitus type 2 . They deliver a GLP-1 agonist directly through the epidermis, avoiding the necessity for regular injections and potenti… Read More